Leptomeningeal Disease Diagnosis in Diffuse Midline Gliomas Achieved via ctDNA Detection
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Read MorePosted by Andy Lundin | Jan 27, 2025 | Unknown Origin & Other Cancer Types |
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Read MorePosted by Andy Lundin | Jan 24, 2025 | Sequencing Systems |
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MorePosted by Andy Lundin | Jan 23, 2025 | Leukemia, Sequencing Systems |
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read MorePosted by Andy Lundin | Jan 23, 2025 | Company News |
HealthTrackRx opened a new campus at the UPS Healthcare Labport in Louisville, enabling next-morning infection diagnostics nationwide.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read More